Global Women's Health Diagnostics Industry

NEW YORK, Oct. 21, 2020 /PRNewswire/ --

Amid the COVID-19 crisis, the global market for Women's Health Diagnostics estimated at US$30.5 Billion in the year 2020, is projected to reach a revised size of US$48 Billion by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027. Breast Cancer Testing, one of the segments analyzed in the report, is projected to record a 7.7% CAGR and reach US$15.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Osteoporosis Testing segment is readjusted to a revised 5.9% CAGR for the next 7-year period.



Read the full report: https://www.reportlinker.com/p05799999/?utm_source=PRN



The U.S. Market is Estimated at $8.2 Billion, While China is Forecast to Grow at 10.3% CAGR

The Women's Health Diagnostics market in the U.S. is estimated at US$8.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.5 Billion by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Ovarian Cancer Testing Segment to Record 6.8% CAGR

In the global Ovarian Cancer Testing segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.9 Billion in the year 2020 will reach a projected size of US$6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.5 Billion by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 287-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • PerkinElmer, Inc.
  • Quest Diagnostics, Inc.
  • Siemens AG





Read the full report: https://www.reportlinker.com/p05799999/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Women's Health Diagnostics Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Women's Health Diagnostics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Women's Health Diagnostics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Women's Health Diagnostics Market Share Shift across
Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Breast Cancer Testing (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027

Table 5: Breast Cancer Testing (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019

Table 6: Breast Cancer Testing (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027

Table 7: Osteoporosis Testing (Application) Worldwide Sales in
US$ Million by Region/Country: 2020-2027

Table 8: Osteoporosis Testing (Application) Historic Demand
Patterns in US$ Million by Region/Country: 2012-2019

Table 9: Osteoporosis Testing (Application) Market Share Shift
across Key Geographies: 2012 VS 2020 VS 2027

Table 10: Ovarian Cancer Testing (Application) Global Market
Estimates & Forecasts in US$ Million by Region/Country:
2020-2027

Table 11: Ovarian Cancer Testing (Application) Retrospective
Demand Analysis in US$ Million by Region/Country: 2012-2019

Table 12: Ovarian Cancer Testing (Application) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 13: Cervical Cancer Testing (Application) Demand
Potential Worldwide in US$ Million by Region/Country: 2020-2027

Table 14: Cervical Cancer Testing (Application) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019

Table 15: Cervical Cancer Testing (Application) Share Breakdown
Review by Region/Country: 2012 VS 2020 VS 2027

Table 16: Genetic Screening and Carrier Testing (Application)
Worldwide Latent Demand Forecasts in US$ Million by
Region/Country: 2020-2027

Table 17: Genetic Screening and Carrier Testing (Application)
Global Historic Analysis in US$ Million by Region/Country:
2012-2019

Table 18: Genetic Screening and Carrier Testing (Application)
Distribution of Global Sales by Region/Country: 2012 VS 2020 VS
2027

Table 19: Other Applications (Application) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2020
through 2027

Table 20: Other Applications (Application) Analysis of Historic
Sales in US$ Million by Region/Country for the Years 2012 to
2019

Table 21: Other Applications (Application) Global Market Share
Distribution by Region/Country for 2012, 2020, and 2027

Table 22: Hospitals & Clinics (End-Use) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027

Table 23: Hospitals & Clinics (End-Use) Historic Sales Analysis
in US$ Million by Region/Country: 2012-2019

Table 24: Hospitals & Clinics (End-Use) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027

Table 25: Diagnostic & Imaging Centers (End-Use) Worldwide
Sales in US$ Million by Region/Country: 2020-2027

Table 26: Diagnostic & Imaging Centers (End-Use) Historic
Demand Patterns in US$ Million by Region/Country: 2012-2019

Table 27: Diagnostic & Imaging Centers (End-Use) Market Share
Shift across Key Geographies: 2012 VS 2020 VS 2027

Table 28: Home Care (End-Use) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027

Table 29: Home Care (End-Use) Retrospective Demand Analysis in
US$ Million by Region/Country: 2012-2019

Table 30: Home Care (End-Use) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Women's Health Diagnostics Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 31: United States Women's Health Diagnostics Latent
Demand Forecasts in US$ Million by Application: 2020 to 2027

Table 32: Women's Health Diagnostics Historic Demand Patterns
in the United States by Application in US$ Million for
2012-2019

Table 33: Women's Health Diagnostics Market Share Breakdown in
the United States by Application: 2012 VS 2020 VS 2027

Table 34: United States Women's Health Diagnostics Latent
Demand Forecasts in US$ Million by End-Use: 2020 to 2027

Table 35: Women's Health Diagnostics Historic Demand Patterns
in the United States by End-Use in US$ Million for 2012-2019

Table 36: Women's Health Diagnostics Market Share Breakdown in
the United States by End-Use: 2012 VS 2020 VS 2027

CANADA
Table 37: Canadian Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 38: Women's Health Diagnostics Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 39: Canadian Women's Health Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 40: Canadian Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 41: Women's Health Diagnostics Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 42: Canadian Women's Health Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

JAPAN
Table 43: Japanese Demand Estimates and Forecasts for Women's
Health Diagnostics in US$ Million by Application: 2020 to 2027

Table 44: Japanese Women's Health Diagnostics Market in US$
Million by Application: 2012-2019

Table 45: Women's Health Diagnostics Market Share Shift in
Japan by Application: 2012 VS 2020 VS 2027

Table 46: Japanese Demand Estimates and Forecasts for Women's
Health Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 47: Japanese Women's Health Diagnostics Market in US$
Million by End-Use: 2012-2019

Table 48: Women's Health Diagnostics Market Share Shift in
Japan by End-Use: 2012 VS 2020 VS 2027

CHINA
Table 49: Chinese Demand for Women's Health Diagnostics in US$
Million by Application: 2020 to 2027

Table 50: Women's Health Diagnostics Market Review in China in
US$ Million by Application: 2012-2019

Table 51: Chinese Women's Health Diagnostics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

Table 52: Chinese Demand for Women's Health Diagnostics in US$
Million by End-Use: 2020 to 2027

Table 53: Women's Health Diagnostics Market Review in China in
US$ Million by End-Use: 2012-2019

Table 54: Chinese Women's Health Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Women's Health Diagnostics Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 55: European Women's Health Diagnostics Market Demand
Scenario in US$ Million by Region/Country: 2020-2027

Table 56: Women's Health Diagnostics Market in Europe:
A Historic Market Perspective in US$ Million by Region/Country
for the Period 2012-2019

Table 57: European Women's Health Diagnostics Market Share
Shift by Region/Country: 2012 VS 2020 VS 2027

Table 58: European Women's Health Diagnostics Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 59: Women's Health Diagnostics Market in Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 60: European Women's Health Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 61: European Women's Health Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 62: Women's Health Diagnostics Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 63: European Women's Health Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

FRANCE
Table 64: Women's Health Diagnostics Quantitative Demand
Analysis in France in US$ Million by Application: 2020-2027

Table 65: French Women's Health Diagnostics Historic Market
Review in US$ Million by Application: 2012-2019

Table 66: French Women's Health Diagnostics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

Table 67: Women's Health Diagnostics Quantitative Demand
Analysis in France in US$ Million by End-Use: 2020-2027

Table 68: French Women's Health Diagnostics Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 69: French Women's Health Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

GERMANY
Table 70: Women's Health Diagnostics Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 71: German Women's Health Diagnostics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 72: Women's Health Diagnostics Market Share Distribution
in Germany by Application: 2012 VS 2020 VS 2027

Table 73: Women's Health Diagnostics Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 74: German Women's Health Diagnostics Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 75: Women's Health Diagnostics Market Share Distribution
in Germany by End-Use: 2012 VS 2020 VS 2027

ITALY
Table 76: Italian Demand for Women's Health Diagnostics in US$
Million by Application: 2020 to 2027

Table 77: Women's Health Diagnostics Market Review in Italy in
US$ Million by Application: 2012-2019

Table 78: Italian Women's Health Diagnostics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

Table 79: Italian Demand for Women's Health Diagnostics in US$
Million by End-Use: 2020 to 2027

Table 80: Women's Health Diagnostics Market Review in Italy in
US$ Million by End-Use: 2012-2019

Table 81: Italian Women's Health Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 82: United Kingdom Demand Estimates and Forecasts for
Women's Health Diagnostics in US$ Million by Application: 2020
to 2027

Table 83: United Kingdom Women's Health Diagnostics Market in
US$ Million by Application: 2012-2019

Table 84: Women's Health Diagnostics Market Share Shift in the
United Kingdom by Application: 2012 VS 2020 VS 2027

Table 85: United Kingdom Demand Estimates and Forecasts for
Women's Health Diagnostics in US$ Million by End-Use: 2020 to
2027

Table 86: United Kingdom Women's Health Diagnostics Market in
US$ Million by End-Use: 2012-2019

Table 87: Women's Health Diagnostics Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027

SPAIN
Table 88: Spanish Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 89: Women's Health Diagnostics Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 90: Spanish Women's Health Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 91: Spanish Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 92: Women's Health Diagnostics Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 93: Spanish Women's Health Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

RUSSIA
Table 94: Russian Women's Health Diagnostics Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 95: Women's Health Diagnostics Historic Demand Patterns
in Russia by Application in US$ Million for 2012-2019

Table 96: Women's Health Diagnostics Market Share Breakdown in
Russia by Application: 2012 VS 2020 VS 2027

Table 97: Russian Women's Health Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 98: Women's Health Diagnostics Historic Demand Patterns
in Russia by End-Use in US$ Million for 2012-2019

Table 99: Women's Health Diagnostics Market Share Breakdown in
Russia by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 100: Rest of Europe Women's Health Diagnostics
Addressable Market Opportunity in US$ Million by Application:
2020-2027

Table 101: Women's Health Diagnostics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 102: Rest of Europe Women's Health Diagnostics Market
Share Analysis by Application: 2012 VS 2020 VS 2027

Table 103: Rest of Europe Women's Health Diagnostics
Addressable Market Opportunity in US$ Million by End-Use:
2020-2027

Table 104: Women's Health Diagnostics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 105: Rest of Europe Women's Health Diagnostics Market
Share Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 106: Asia-Pacific Women's Health Diagnostics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 107: Women's Health Diagnostics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019

Table 108: Asia-Pacific Women's Health Diagnostics Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 109: Women's Health Diagnostics Quantitative Demand
Analysis in Asia-Pacific in US$ Million by Application:
2020-2027

Table 110: Asia-Pacific Women's Health Diagnostics Historic
Market Review in US$ Million by Application: 2012-2019

Table 111: Asia-Pacific Women's Health Diagnostics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

Table 112: Women's Health Diagnostics Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 113: Asia-Pacific Women's Health Diagnostics Historic
Market Review in US$ Million by End-Use: 2012-2019

Table 114: Asia-Pacific Women's Health Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

AUSTRALIA
Table 115: Women's Health Diagnostics Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 116: Australian Women's Health Diagnostics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 117: Women's Health Diagnostics Market Share Distribution
in Australia by Application: 2012 VS 2020 VS 2027

Table 118: Women's Health Diagnostics Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by End-Use
for the Period 2020-2027

Table 119: Australian Women's Health Diagnostics Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 120: Women's Health Diagnostics Market Share Distribution
in Australia by End-Use: 2012 VS 2020 VS 2027

INDIA
Table 121: Indian Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 122: Women's Health Diagnostics Market in India:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 123: Indian Women's Health Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 124: Indian Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 125: Women's Health Diagnostics Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 126: Indian Women's Health Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 127: Women's Health Diagnostics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Application for the Period 2020-2027

Table 128: South Korean Women's Health Diagnostics Historic
Market Analysis in US$ Million by Application: 2012-2019

Table 129: Women's Health Diagnostics Market Share Distribution
in South Korea by Application: 2012 VS 2020 VS 2027

Table 130: Women's Health Diagnostics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2020-2027

Table 131: South Korean Women's Health Diagnostics Historic
Market Analysis in US$ Million by End-Use: 2012-2019

Table 132: Women's Health Diagnostics Market Share Distribution
in South Korea by End-Use: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for Women's Health Diagnostics in US$ Million by Application:
2020 to 2027

Table 134: Rest of Asia-Pacific Women's Health Diagnostics
Market in US$ Million by Application: 2012-2019

Table 135: Women's Health Diagnostics Market Share Shift in
Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027

Table 136: Rest of Asia-Pacific Demand Estimates and Forecasts
for Women's Health Diagnostics in US$ Million by End-Use: 2020
to 2027

Table 137: Rest of Asia-Pacific Women's Health Diagnostics
Market in US$ Million by End-Use: 2012-2019

Table 138: Women's Health Diagnostics Market Share Shift in
Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 139: Latin American Women's Health Diagnostics Market
Trends by Region/Country in US$ Million: 2020-2027

Table 140: Women's Health Diagnostics Market in Latin America
in US$ Million by Region/Country: A Historic Perspective for
the Period 2012-2019

Table 141: Latin American Women's Health Diagnostics Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027

Table 142: Latin American Demand for Women's Health Diagnostics
in US$ Million by Application: 2020 to 2027

Table 143: Women's Health Diagnostics Market Review in Latin
America in US$ Million by Application: 2012-2019

Table 144: Latin American Women's Health Diagnostics Market
Share Breakdown by Application: 2012 VS 2020 VS 2027

Table 145: Latin American Demand for Women's Health Diagnostics
in US$ Million by End-Use: 2020 to 2027

Table 146: Women's Health Diagnostics Market Review in Latin
America in US$ Million by End-Use: 2012-2019

Table 147: Latin American Women's Health Diagnostics Market
Share Breakdown by End-Use: 2012 VS 2020 VS 2027

ARGENTINA
Table 148: Argentinean Women's Health Diagnostics Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 149: Women's Health Diagnostics Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 150: Argentinean Women's Health Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 151: Argentinean Women's Health Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 152: Women's Health Diagnostics Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 153: Argentinean Women's Health Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

BRAZIL
Table 154: Women's Health Diagnostics Quantitative Demand
Analysis in Brazil in US$ Million by Application: 2020-2027

Table 155: Brazilian Women's Health Diagnostics Historic Market
Review in US$ Million by Application: 2012-2019

Table 156: Brazilian Women's Health Diagnostics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

Table 157: Women's Health Diagnostics Quantitative Demand
Analysis in Brazil in US$ Million by End-Use: 2020-2027

Table 158: Brazilian Women's Health Diagnostics Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 159: Brazilian Women's Health Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

MEXICO
Table 160: Women's Health Diagnostics Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 161: Mexican Women's Health Diagnostics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 162: Women's Health Diagnostics Market Share Distribution
in Mexico by Application: 2012 VS 2020 VS 2027

Table 163: Women's Health Diagnostics Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 164: Mexican Women's Health Diagnostics Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 165: Women's Health Diagnostics Market Share Distribution
in Mexico by End-Use: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 166: Rest of Latin America Women's Health Diagnostics
Latent Demand Forecasts in US$ Million by Application: 2020 to
2027

Table 167: Women's Health Diagnostics Historic Demand Patterns
in Rest of Latin America by Application in US$ Million for
2012-2019

Table 168: Women's Health Diagnostics Market Share Breakdown in
Rest of Latin America by Application: 2012 VS 2020 VS 2027

Table 169: Rest of Latin America Women's Health Diagnostics
Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027

Table 170: Women's Health Diagnostics Historic Demand Patterns
in Rest of Latin America by End-Use in US$ Million for
2012-2019

Table 171: Women's Health Diagnostics Market Share Breakdown in
Rest of Latin America by End-Use: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 172: The Middle East Women's Health Diagnostics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 173: Women's Health Diagnostics Market in the Middle East
by Region/Country in US$ Million: 2012-2019

Table 174: The Middle East Women's Health Diagnostics Market
Share Breakdown by Region/Country: 2012, 2020, and 2027

Table 175: The Middle East Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 176: Women's Health Diagnostics Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by Application for 2012-2019

Table 177: The Middle East Women's Health Diagnostics Market
Share Analysis by Application: 2012 VS 2020 VS 2027

Table 178: The Middle East Women's Health Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 179: Women's Health Diagnostics Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by End-Use for 2012-2019

Table 180: The Middle East Women's Health Diagnostics Market
Share Analysis by End-Use: 2012 VS 2020 VS 2027

IRAN
Table 181: Iranian Demand Estimates and Forecasts for Women's
Health Diagnostics in US$ Million by Application: 2020 to 2027

Table 182: Iranian Women's Health Diagnostics Market in US$
Million by Application: 2012-2019

Table 183: Women's Health Diagnostics Market Share Shift in
Iran by Application: 2012 VS 2020 VS 2027

Table 184: Iranian Demand Estimates and Forecasts for Women's
Health Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 185: Iranian Women's Health Diagnostics Market in US$
Million by End-Use: 2012-2019

Table 186: Women's Health Diagnostics Market Share Shift in
Iran by End-Use: 2012 VS 2020 VS 2027

ISRAEL
Table 187: Israeli Women's Health Diagnostics Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 188: Women's Health Diagnostics Market in Israel:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 189: Israeli Women's Health Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

Table 190: Israeli Women's Health Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 191: Women's Health Diagnostics Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 192: Israeli Women's Health Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 193: Saudi Arabian Demand for Women's Health Diagnostics
in US$ Million by Application: 2020 to 2027

Table 194: Women's Health Diagnostics Market Review in Saudi
Arabia in US$ Million by Application: 2012-2019

Table 195: Saudi Arabian Women's Health Diagnostics Market
Share Breakdown by Application: 2012 VS 2020 VS 2027

Table 196: Saudi Arabian Demand for Women's Health Diagnostics
in US$ Million by End-Use: 2020 to 2027

Table 197: Women's Health Diagnostics Market Review in Saudi
Arabia in US$ Million by End-Use: 2012-2019

Table 198: Saudi Arabian Women's Health Diagnostics Market
Share Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED ARAB EMIRATES
Table 199: Women's Health Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2020-2027

Table 200: United Arab Emirates Women's Health Diagnostics
Historic Market Analysis in US$ Million by Application:
2012-2019

Table 201: Women's Health Diagnostics Market Share Distribution
in United Arab Emirates by Application: 2012 VS 2020 VS 2027

Table 202: Women's Health Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2020-2027

Table 203: United Arab Emirates Women's Health Diagnostics
Historic Market Analysis in US$ Million by End-Use: 2012-2019

Table 204: Women's Health Diagnostics Market Share Distribution
in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 205: Women's Health Diagnostics Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 206: Rest of Middle East Women's Health Diagnostics
Market in Retrospect in US$ Million by Application: 2012-2019

Table 207: Women's Health Diagnostics Market Share Distribution
in Rest of Middle East by Application: 2012 VS 2020 VS 2027

Table 208: Women's Health Diagnostics Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2020-2027

Table 209: Rest of Middle East Women's Health Diagnostics
Market in Retrospect in US$ Million by End-Use: 2012-2019

Table 210: Women's Health Diagnostics Market Share Distribution
in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027

AFRICA
Table 211: African Women's Health Diagnostics Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 212: Women's Health Diagnostics Historic Demand Patterns
in Africa by Application in US$ Million for 2012-2019

Table 213: Women's Health Diagnostics Market Share Breakdown in
Africa by Application: 2012 VS 2020 VS 2027

Table 214: African Women's Health Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 215: Women's Health Diagnostics Historic Demand Patterns
in Africa by End-Use in US$ Million for 2012-2019

Table 216: Women's Health Diagnostics Market Share Breakdown in
Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 41
Read the full report: https://www.reportlinker.com/p05799999/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com  
US: (339)-368-6001
Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/global-womens-health-diagnostics-industry-301156678.html

SOURCE Reportlinker

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.